| Literature DB >> 31328185 |
Kevin Rhie1, Danielle M Feger1, Rayford R June1, Christopher N Sciamanna1, Sharon E Banks1.
Abstract
BACKGROUND: Exercise has proven benefits in rheumatologic disease including reducing inflammation and improving symptoms. A Group Strength Training (GST) program design has improved adherence to exercise in primary care patients but the effect is unknown in rheumatology patients. We examined the interest of rheumatology patients with different diagnoses and the effect of comorbidities in pursuing an organized GST program.Entities:
Keywords: Exercise; Group; Interest; Rheumatology; Strength
Year: 2019 PMID: 31328185 PMCID: PMC6641551 DOI: 10.23937/2469-5718/1510121
Source DB: PubMed Journal: Int J Sports Exerc Med
Demographics.
| Item | Overall | Rheumatoid Arthritis | Osteoarthritis | Fibromyalgia |
|---|---|---|---|---|
| 52.0 (SD = 15.4) | 53.2 (SD = 15.0) | 60.0 (SD = 11.5) | 48.0 (SD = 13.5) | |
| 18–44 | 121 (32.4%) | 39 (26.9%) | 6 (8.0%) | 31 (38.3%) |
| 45–54 | 81 (21.7%) | 36 (24.8%) | 18 (24.0%) | 25 (30.9%) |
| 55–64 | 91 (24.3%) | 28 (26.2%) | 22 (29.3%) | 18 (22.2%) |
| ≥ 65 | 81 (21.7%) | 32 (22.1%) | 29 (38.7%) | 7 (8.6%) |
| Female | 300 (80.0%) | 113 (77.9%) | 64 (85.3%) | 73 (90.1%) |
| Caucasian | 323 (81.2%) | 121 (78.1%) | 66 (84.6%) | 72 (84.7%) |
| Hispanic | 34 (9.2%) | 14 (9.7%) | 6 (8.1%) | 8 (10.1%) |
| Current Smoker | 66 (17.2%) | 25 (17.0%) | 11 (14.3%) | 21 (26.3%) |
| < High School | 24 (6.5%) | 14 (9.8%) | 6 (8.0%) | 4 (4.9%) |
| High School | 115 (31.2%) | 42 (29.4%) | 22 (29.3%) | 23 (28.1%) |
| Some College | 116 (31.4%) | 47 (32.9%) | 30 (40.0%) | 40 (48.8%) |
| College or Higher | 115 (31.1%) | 40 (28.0%) | 17 (22.7%) | 15 (18.3%) |
| BMI (kg/m2) | 30.2 (SD = 7.9) | 29.9 (SD = 7.9) | 32.0 (SD = 9.1) | 31.2 (SD = 7.8) |
| ≤ 25 | 100 (28.6%) | 39 (29.1%) | 12 (17.9%) | 16 (21.9%) |
| 25–30 | 97 (27.7%) | 41 (30.6%) | 22 (32.8%) | 19 (26.0%) |
| > 30 | 153 (43.7%) | 54 (40.3%) | 33 (49.3%) | 38 (52.1%) |
| Diabetes | 52 (14.2%) | 20 (14.5%) | 13 (17.8%) | 10 (13.0%) |
| High Cholesterol | 123 (33.5%) | 46 (32.9%) | 34 (47.2%) | 22 (28.2%) |
| Hypertension | 151 (40.3%) | 53 (37.1%) | 38 (52.1%) | 31 (38.8%) |
| Coronary Artery Disease | 34 (9.2%) | 14 (9.7%) | 8 (11.0%) | 5 (6.5%) |
| Fibromyalgia | 85 (21.4%) | 26 (16.8%) | 31 (41.0%) | 85 (100.0%) |
| 2.2 (SD = 2.3) | 2.0 (SD = 2.2) | 2.0 (SD = 2.1) | 2.3 (SD = 2.3) | |
| 0 | 132 (36.8%) | 57 (40.7%) | 24 (35.3%) | 26 (34.7%) |
| 1–3 | 133 (37.1%) | 50 (35.7%) | 30 (44.1%) | 28 (37.3%) |
| 4–7 | 94 (26.2%) | 33 (23.6%) | 14 (20.6%) | 21 (28.0%) |
| 1.4 (2.0) | 1.5 (2.1) | 1.1 (1.7) | 1.0 (1.7) | |
| 0 | 211 (58.8%) | 78 (56.9%) | 44 (61.1%) | 51 (64.6%) |
| 1–3 | 94 (26.2%) | 37 (27.0%) | 20 (27.8%) | 19 (24.1%) |
| 4–7 | 54 (15.0%) | 22 (16.1%) | 8 (11.1%) | 9 (11.4%) |
| None | 99 (27.3%) | 44 (31.4%) | 18 (25.0%) | 23 (29.5%) |
| 1+ Days/Week | 264 (72.7%) | 96 (68.6%) | 54 (75.0%) | 55 (70.5%) |
| Excellent | 11 (2.8%) | 2 (1.3%) | 1 (1.3%) | 0 (0.0%) |
| Very Good | 75 (19.2%) | 23 (15.1%) | 8 (10.3%) | 6 (7.2%) |
| Good | 128 (32.8%) | 51 (33.6%) | 32 (41.0%) | 23 (27.7%) |
| Fair | 135 (34.6%) | 57 (37.5%) | 26 (33.3%) | 36 (43.4%) |
| Poor | 41 (10.5%) | 19 (12.5%) | 11 (14.1%) | 18 (21.7%) |
| 13.6 (SD = 10.6) | 14.2 (SD = 10.4) | 13.7 (SD = 10.7) | 18.0 (SD = 9.6) | |
| 0 | 49 (13.9%) | 17 (12.6%) | 8 (12.5%) | 4 (5.3%) |
| 1–9 | 84 (23.9%) | 28 (20.7%) | 17 (26.6%) | 11 (14.7%) |
| ≥ 10 | 219 (62.2%) | 90 (66.7%) | 39 (60.9%) | 60 (80.0%) |
| 9.8 (SD = 10.7) | 9.2 (SD = 10.6) | 9.7 (SD = 10.6) | 13.6 (SD = 11.3) | |
| 0 | 117 (33.0%) | 54 (39.7%) | 24 (35.8%) | 12 (15.6%) |
| 1–9 | 80 (22.5%) | 24 (17.7%) | 13 (19.4%) | 20 (26.0%) |
| ≥ 10 | 158 (44.5%) | 58 (42.7%) | 30 (44.8%) | 45 (58.4%) |
Comparison between persons interested in Group Strength Training and not interested.
| Item | Interest N = (%) | No Interest N = (%) | P-value |
|---|---|---|---|
| Age (Years) | 51.6 (SD = 14.8) | 51.5 (SD = 16.3) | 0.95 |
| 18–44 | 57 (48.7%) | 60 (51.3%) | |
| 45–54 | 36 (46.2%) | 42 (53.9%) | |
| 55–64 | 47 (57.3%) | 35 (42.7%) | |
| ≥ 65 | 35 (48.0%) | 38 (52.1%) | |
| Female | 155 (88.1%) | 127 (73.0%) | 0.0004[ |
| Caucasian | 150 (85.2%) | 153 (87.4%) | 0.55 |
| Hispanic | 14 (8.0%) | 16 (9.4%) | 0.63 |
| Current Smoker | 26 (44.1%) | 33 (55.9%) | 0.28 |
| 0.11 | |||
| < High School | 6 (28.6%) | 15 (71.4%) | |
| High School | 49 (45.8%) | 58 (54.2%) | |
| Some College | 61 (55.5%) | 49 (44.6%) | |
| College or Higher | 56 (51.9%) | 52 (41.2%) | |
| BMI (kg/m2) | 31.1 (SD = 7.9) | 29.7 (SD = 8.1) | 0.10 |
| ≤ 25 | 39 (42.9%) | 52 (57.1%) | |
| 25–30 | 46 (51.7%) | 43 (48.3%) | |
| >30 | 84 (56.0%) | 66 (44.0%) | |
| Diabetes | 25 (56.8%) | 19 (43.2%) | 0.44 |
| High Cholesterol | 66 (56.4%) | 51 (43.6%) | 0.17 |
| Hypertension | 72 (53.7%) | 62 (46.3%) | 0.42 |
| Coronary Artery Disease | 13 (40.6%) | 19 (59.4%) | 0.22 |
| Fibromyalgia | 38 (48.7%) | 40 (51.3%) | 0.78 |
| 2.3 (SD = 2.2) | 2.0 (SD = 2.3) | 0.63 | |
| 0 (%) | 55 (46.6%) | 63 (53.4%) | |
| 1–3 (%) | 66 (51.6%) | 62 (48.4%) | |
| 4–7 (%) | 47 (54.7%) | 39 (45.4%) | |
| 1.4 (SD = 2.0) | 1.4 (SD = 2.1) | 1.00 | |
| 0 (%) | 94 (48.7%) | 99 (51.3%) | |
| 1–3 (%) | 51 (56.0%) | 40 (44.0%) | |
| 4–7 (%) | 22 (44.9%) | 27 (55.1%) | |
| 0.28 | |||
| None | 42 (46.2%) | 49 (53.9%) | |
| 1+ Days/Week | 130 (52.9%) | 116 (47.2%) | |
| 0.16 | |||
| Excellent (%) | 2 (20.0%) | 8 (80.0%) | |
| Very Good (%) | 30 (45.5%) | 36 (55.6%) | |
| Good (%) | 63 (53.9%) | 54 (46.2%) | |
| Fair (%) | 64 (53.8%) | 55 (46.2%) | |
| Poor (%) | 13 (40.6%) | 19 (59.4%) | |
| 13.7 (SD = 10.0) | 13.0 (SD = 10.8) | 0.96 | |
| 0 (%) | 18 (40.9%) | 26 (59.1%) | |
| 1–9 (%) | 39 (49.4%) | 40 (50.6%) | |
| ≥ 10 (%) | 108 (54.6%) | 90 (45.5%) | |
| 9.8 (10.6) | 9.4 (10.7) | 0.99 | |
| 0 (%) | 51 (47.7%) | 56 (52.3%) | |
| 1–9 (%) | 43 (55.8%) | 34 (44.2%) | |
| ≥ 10 (%) | 74 (52.1%) | 68 (47.9%) |
P < 0.05.
Comparison between persons interested in Group Strength Training and not interested by diagnosis.
| Item | Interested | Not Interested | P-value |
|---|---|---|---|
| Rheumatoid Arthritis | 64 (48.9%) | 67 (51.2%) | 0.71 |
| Lupus | 28 (58.3%) | 20 (41.7%) | 0.22 |
| Psoriatic Arthritis | 16 (48.5%) | 17 (51.5%) | 0.84 |
| Osteoarthritis | 34 (50.0%) | 34 (50.0%) | 0.98 |
| Fibromyalgia | 38 (48.7%) | 40 (51.3%) | 0.78 |
| Ankylosing Spondylitis | 8 (57.1%) | 6 (42.3%) | 0.59 |
| Sjogren’s Syndrome | 17 (54.8%) | 14 (45.2%) | 0.58 |